234 related articles for article (PubMed ID: 10864915)
1. Human vascular adhesion protein-1 (VAP-1) plays a critical role in lymphocyte-endothelial cell adhesion cascade under shear.
Salmi M; Tohka S; Jalkanen S
Circ Res; 2000 Jun; 86(12):1245-51. PubMed ID: 10864915
[TBL] [Abstract][Full Text] [Related]
2. Vascular adhesion protein-1 mediates adhesion and transmigration of lymphocytes on human hepatic endothelial cells.
Lalor PF; Edwards S; McNab G; Salmi M; Jalkanen S; Adams DH
J Immunol; 2002 Jul; 169(2):983-92. PubMed ID: 12097405
[TBL] [Abstract][Full Text] [Related]
3. Vascular adhesion protein 1 (VAP-1) mediates lymphocyte subtype-specific, selectin-independent recognition of vascular endothelium in human lymph nodes.
Salmi M; Tohka S; Berg EL; Butcher EC; Jalkanen S
J Exp Med; 1997 Aug; 186(4):589-600. PubMed ID: 9254657
[TBL] [Abstract][Full Text] [Related]
4. Human vascular adhesion protein 1 (VAP-1) is a unique sialoglycoprotein that mediates carbohydrate-dependent binding of lymphocytes to endothelial cells.
Salmi M; Jalkanen S
J Exp Med; 1996 Feb; 183(2):569-79. PubMed ID: 8627168
[TBL] [Abstract][Full Text] [Related]
5. Vascular adhesion protein 1 (VAP-1) functions as a molecular brake during granulocyte rolling and mediates recruitment in vivo.
Tohka S; Laukkanen M; Jalkanen S; Salmi M
FASEB J; 2001 Feb; 15(2):373-82. PubMed ID: 11156953
[TBL] [Abstract][Full Text] [Related]
6. The oxidase activity of vascular adhesion protein-1 (VAP-1) induces endothelial E- and P-selectins and leukocyte binding.
Jalkanen S; Karikoski M; Mercier N; Koskinen K; Henttinen T; Elima K; Salmivirta K; Salmi M
Blood; 2007 Sep; 110(6):1864-70. PubMed ID: 17548577
[TBL] [Abstract][Full Text] [Related]
7. Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule.
Smith DJ; Salmi M; Bono P; Hellman J; Leu T; Jalkanen S
J Exp Med; 1998 Jul; 188(1):17-27. PubMed ID: 9653080
[TBL] [Abstract][Full Text] [Related]
8. A cell surface amine oxidase directly controls lymphocyte migration.
Salmi M; Yegutkin GG; Lehvonen R; Koskinen K; Salminen T; Jalkanen S
Immunity; 2001 Mar; 14(3):265-76. PubMed ID: 11290336
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte binding to vascular endothelium in inflamed skin revisited: a central role for vascular adhesion protein-1 (VAP-1).
Arvilommi AM; Salmi M; Kalimo K; Jalkanen S
Eur J Immunol; 1996 Apr; 26(4):825-33. PubMed ID: 8625974
[TBL] [Abstract][Full Text] [Related]
10. CD73 is involved in lymphocyte binding to the endothelium: characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73.
Airas L; Hellman J; Salmi M; Bono P; Puurunen T; Smith DJ; Jalkanen S
J Exp Med; 1995 Nov; 182(5):1603-8. PubMed ID: 7595232
[TBL] [Abstract][Full Text] [Related]
11. The role of two distinct endothelial molecules, vascular adhesion protein-1 and peripheral lymph node addressin, in the binding of lymphocyte subsets to human lymph nodes.
Salmi M; Hellman J; Jalkanen S
J Immunol; 1998 Jun; 160(11):5629-36. PubMed ID: 9605169
[TBL] [Abstract][Full Text] [Related]
12. Human leukocyte subpopulations from inflamed gut bind to joint vasculature using distinct sets of adhesion molecules.
Salmi M; Jalkanen S
J Immunol; 2001 Apr; 166(7):4650-7. PubMed ID: 11254724
[TBL] [Abstract][Full Text] [Related]
13. Function-blocking antibodies to human vascular adhesion protein-1: a potential anti-inflammatory therapy.
Kirton CM; Laukkanen ML; Nieminen A; Merinen M; Stolen CM; Armour K; Smith DJ; Salmi M; Jalkanen S; Clark MR
Eur J Immunol; 2005 Nov; 35(11):3119-30. PubMed ID: 16224816
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte transmigration through the endothelium is regulated by the oxidase activity of vascular adhesion protein-1 (VAP-1).
Koskinen K; Vainio PJ; Smith DJ; Pihlavisto M; Ylä-Herttuala S; Jalkanen S; Salmi M
Blood; 2004 May; 103(9):3388-95. PubMed ID: 14726375
[TBL] [Abstract][Full Text] [Related]
15. Carbohydrates located on the top of the "cap" contribute to the adhesive and enzymatic functions of vascular adhesion protein-1.
Maula SM; Salminen T; Kaitaniemi S; Nymalm Y; Smith DJ; Jalkanen S
Eur J Immunol; 2005 Sep; 35(9):2718-27. PubMed ID: 16082728
[TBL] [Abstract][Full Text] [Related]
16. Vascular adhesion protein-1 (VAP-1) mediates lymphocyte-endothelial interactions in chronic kidney rejection.
Kurkijärvi R; Jalkanen S; Isoniemi H; Salmi M
Eur J Immunol; 2001 Oct; 31(10):2876-84. PubMed ID: 11592062
[TBL] [Abstract][Full Text] [Related]
17. Vascular adhesion protein-1 and ICAM-1 support the adhesion of tumor-infiltrating lymphocytes to tumor endothelium in human hepatocellular carcinoma.
Yoong KF; McNab G; Hübscher SG; Adams DH
J Immunol; 1998 Apr; 160(8):3978-88. PubMed ID: 9558106
[TBL] [Abstract][Full Text] [Related]
18. Neutrophils, monocytes, and lymphocytes bind to cytokine-activated kidney glomerular endothelial cells through L-selectin (LAM-1) in vitro.
Brady HR; Spertini O; Jimenez W; Brenner BM; Marsden PA; Tedder TF
J Immunol; 1992 Oct; 149(7):2437-44. PubMed ID: 1382103
[TBL] [Abstract][Full Text] [Related]
19. A novel endothelial cell molecule mediating lymphocyte binding in humans.
Jalkanen S; Salmi M
Behring Inst Mitt; 1993 Aug; (92):36-43. PubMed ID: 8250815
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte-vascular adhesion protein-2 is a novel 70-kDa molecule involved in lymphocyte adhesion to vascular endothelium.
Airas L; Salmi M; Jalkanen S
J Immunol; 1993 Oct; 151(8):4228-38. PubMed ID: 8409398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]